NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow ALS progression in early trial
Disease control Not yet recruitingThis study tests an oral drug called Kamlanoflast in 40 people with ALS. The goal is to see if it is safe, tolerable, and can reduce inflammation and slow decline in muscle function over 24 weeks. Participants must be 18-75 years old, diagnosed with ALS, and have had symptoms for…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Could a new cycling style ease MS symptoms?
Symptom relief Not yet recruitingThis study will test a new type of exercise called eccentric cycling for people with multiple sclerosis (MS). The goal is to see if this cycling method can improve muscle strength, walking ability, fatigue, and quality of life better than standard training. The study plans to enr…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC